190 related articles for article (PubMed ID: 37021547)
1. Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity.
O'Brien C; Ling T; Berman JM; Culp-Hill R; Reisz JA; Rondeau V; Jahangiri S; St-Germain J; Macwan V; Astori A; Zeng A; Hong JY; Li M; Yang M; Jana S; Gamboni F; Tsao E; Liu W; Dick JE; Lin H; Melnick A; Tikhonova A; Arruda A; Minden MD; Raught B; D'Alessandro A; Jones CL
Haematologica; 2023 Sep; 108(9):2343-2357. PubMed ID: 37021547
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation.
Zhang Y; Shen Y; Wei W; Wang W; Jiang D; Ren Y; Peng Z; Fan Q; Cheng J; Ma J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955415
[TBL] [Abstract][Full Text] [Related]
3. Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.
Griessinger E; Pereira-Martins D; Nebout M; Bosc C; Saland E; Boet E; Sahal A; Chiche J; Debayle D; Fleuriot L; Pruis M; De Mas V; Vergez F; Récher C; Huls G; Sarry JE; Schuringa JJ; Peyron JF
Cancer Res; 2023 Aug; 83(15):2461-2470. PubMed ID: 37272750
[TBL] [Abstract][Full Text] [Related]
4. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
[TBL] [Abstract][Full Text] [Related]
5. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice.
Li M; Li CM; Ye ZC; Huang J; Li Y; Lai W; Peng H; Lou TQ
J Cell Mol Med; 2020 May; 24(9):5109-5121. PubMed ID: 32281286
[TBL] [Abstract][Full Text] [Related]
6. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Jones CL; Stevens BM; D'Alessandro A; Reisz JA; Culp-Hill R; Nemkov T; Pei S; Khan N; Adane B; Ye H; Krug A; Reinhold D; Smith C; DeGregori J; Pollyea DA; Jordan CT
Cancer Cell; 2018 Nov; 34(5):724-740.e4. PubMed ID: 30423294
[TBL] [Abstract][Full Text] [Related]
8. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 3 improves fatty acid metabolism in response to high nonesterified fatty acids in calf hepatocytes by modulating gene expression.
Liu L; Xing D; Du X; Peng T; McFadden JW; Wen L; Lei H; Dong W; Liu G; Wang Z; Su J; He J; Li X
J Dairy Sci; 2020 Jul; 103(7):6557-6568. PubMed ID: 32331890
[TBL] [Abstract][Full Text] [Related]
10. Can we selectively target AML stem cells?
Jordan CT
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101100. PubMed ID: 31779978
[TBL] [Abstract][Full Text] [Related]
11. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
12. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
13. Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.
Culp-Hill R; Stevens BM; Jones CL; Pei S; Dzieciatkowska M; Minhajuddin M; Jordan CT; D'Alessandro A
Metabolites; 2023 Mar; 13(4):. PubMed ID: 37110126
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.
Li S; Dou X; Ning H; Song Q; Wei W; Zhang X; Shen C; Li J; Sun C; Song Z
Hepatology; 2017 Sep; 66(3):936-952. PubMed ID: 28437863
[TBL] [Abstract][Full Text] [Related]
15. A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Pei S; Shelton IT; Gillen AE; Stevens BM; Gasparetto M; Wang Y; Liu L; Liu J; Brunetti TM; Engel K; Staggs S; Showers W; Sheth AI; Amaya ML; Minhajuddin M; Winters A; Patel SB; Tolison H; Krug AE; Young TN; Schowinsky J; McMahon CM; Smith CA; Pollyea DA; Jordan CT
Cancer Discov; 2023 Sep; 13(9):2032-2049. PubMed ID: 37358260
[TBL] [Abstract][Full Text] [Related]
16. Turning Down the Temperature on Leukemia Stem Cells.
Jones CL
Cancer Res; 2023 Aug; 83(15):2441-2442. PubMed ID: 37525977
[TBL] [Abstract][Full Text] [Related]
17. CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.
He L; Arnold C; Thoma J; Rohde C; Kholmatov M; Garg S; Hsiao CC; Viol L; Zhang K; Sun R; Schmidt C; Janssen M; MacRae T; Huber K; Thiede C; Hébert J; Sauvageau G; Spratte J; Fluhr H; Aust G; Müller-Tidow C; Niehrs C; Pereira G; Hamann J; Tanaka M; Zaugg JB; Pabst C
EMBO Mol Med; 2022 Apr; 14(4):e14990. PubMed ID: 35253392
[TBL] [Abstract][Full Text] [Related]
18. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.
Hirschey MD; Shimazu T; Goetzman E; Jing E; Schwer B; Lombard DB; Grueter CA; Harris C; Biddinger S; Ilkayeva OR; Stevens RD; Li Y; Saha AK; Ruderman NB; Bain JR; Newgard CB; Farese RV; Alt FW; Kahn CR; Verdin E
Nature; 2010 Mar; 464(7285):121-5. PubMed ID: 20203611
[TBL] [Abstract][Full Text] [Related]
20. Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
Jones CL; Stevens BM; D'Alessandro A; Culp-Hill R; Reisz JA; Pei S; Gustafson A; Khan N; DeGregori J; Pollyea DA; Jordan CT
Blood; 2019 Jul; 134(4):389-394. PubMed ID: 31101624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
